Tennessee Oncology Nashville (Sarah Cannon Research Institute) — Nashville, Tennessee

Tennessee Oncology Nashville (Sarah Cannon Research Institute) is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Tennessee Oncology Nashville (Sarah Cannon Research Institute) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Endometrial Cancer.

Sponsors: Karyopharm Therapeutics Inc.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology Nashville (Sarah Cannon Research Institute)?

Tennessee Oncology Nashville (Sarah Cannon Research Institute) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology Nashville (Sarah Cannon Research Institute) conducted?

Tennessee Oncology Nashville (Sarah Cannon Research Institute) has 1 clinical trials on record, with 1 currently active. Their work covers Endometrial Cancer.

Is Tennessee Oncology Nashville (Sarah Cannon Research Institute) accredited by Crixeo Health?

Tennessee Oncology Nashville (Sarah Cannon Research Institute) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tennessee Oncology Nashville (Sarah Cannon Research Institute)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.